PrEP Quarterly Report for British Columbia – Second Quarter 2020
PrEP Quarterly Report for British Columbia – Second Quarter 2020 Read More »
The UK Government has now made PrEP available for free across England – but many gay and bi men will still struggle to get it. Pilot projects have found the drug is highly effective in cutting HIV transmission. But the government refused to fund it for years. And now it has announced the funding just
England makes PrEP free but getting it will still be a postcode lottery for now Read More »
The dramatic saga of the acquired immunodeficiency syndrome (AIDS) features an early sense of helplessness and frustration in the face of a mysterious new disease, courage on the part of the afflicted, and the gradual accrual of groundbreaking scientific advances that have brought hope to a formerly desperate situation. This progress began with a series
Four Decades of HIV/AIDS – Much Accomplished, Much to Do Read More »
This year, the annual Conference on Retroviruses and Opportunistic Infections (CROI) was held in a virtual format due to the COVID-19 coronavirus outbreak. For the first in our video coverage series for 2020’s meeting, we’re revisiting a feature from 10 years ago on the future of HIV research, which is not so different from the
Flashback: Anthony Fauci on the HIV Epidemic 10 Years Ago Read More »
South African HIV advocates say there is an urgent need for the government to make PrEP available to everyone who needs it This comes after the announcement made earlier this week by the National Institute of Allergy and Infectious Diseases (NIAID) about the non-efficacy of the HIV-prevention vaccine in the HVTN 702 clinical trial. Speaking
This is not the time to give up, says SA HIV advocates Read More »
More gay and bisexual men are using HIV pre-exposure prophylaxis (PrEP) with increased confidence in the benefits of HIV treatment for prevention, according to a UNSW study. Significantly more gay and bisexual men are using the antiretroviral drug PrEP to prevent HIV infection, according to the latest report from the PrEPARE Project. The national online
Increased use of and confidence in antiretroviral PrEP for prevention of HIV found Read More »
The Centers for Disease Control and Prevention announced that PrEP among at-risk men increased 500 percent between 2014 to 2017. And those numbers are expected to rise following Gilead Sciences’ new commitment to donate up to 2.4 million bottles of Truvada to the CDC by 2030 (which amounts to 200,000 per year). The study is
PrEP Use Up 500 Percent In Just Three Years Read More »
Earlier this month, pharmaceutical company Gilead Sciences announced that it will donate enough HIV prevention drug Truvada to the Centers for Disease Control and Prevention (CDC) to benefit 200,000 people at risk for HIV. While news of the announcement was met positively, it also came ahead of some other negative headlines surrounding the drugmaker, coupled
Drugmaker Gilead Is Making HIV Prevention Meds More Accessible Read More »